TET1 and B-cell non-Hodgkin lymphoma: Moreover, hypermethylation and thus transcriptional silencing of TET1 is also observed in B-cell lymphoma, where its tumor suppressor activity was demonstrated in vivo, as KO of TET1 resulted in decreased survival of the mice (163).